Dr. Einhorn explains how he diagnoses women with type 2 diabetes.
Type 2 diabetes is diagnosed by blood sugar, and that’s an interesting issue. When does type 2 diabetes really begin in a rise of blood sugar because there is normal fasting blood sugar when you wake up and that’s less than 100, maybe less than 90, that’s normal. We don’t define type 2 diabetes until your fasting blood sugar is more than 126 on a couple of occasions, and that number comes from about the point where we see complications of sugar, but there’s a gap between normal and what’s called diabetes and that’s called impaired fasting glucose.
We’re understanding more about what to do for people of that gap, but certainly if your fasting blood sugar is consistently above 126, in America, you have type 2 diabetes. Another way it’s diagnosed is by after-meal blood sugar or after-glucose challenge blood sugar.
Normal, you’ll never go above 140. Diabetes we call 200 and above. So if after a challenge or after a meal you have a blood sugar in the 200s or more, you have type 2 diabetes.
About Dr. Einhorn:
Dr. Daniel Einhorn received his undergraduate degree from Yale University, his medical degree from Tufts University School of Medicine, and his internship, residency and fellowship at Harvard Medical School. He served on the faculty of Harvard until coming to San Diego in 1984, and has since been a clinical endocrinologist with Diabetes and Endocrine Associates, Associate Clinical Professor of Medicine (Voluntary) at University of California, San Diego, and, until 2000, the Medical Director of the Diabetes Treatment and Research Center at Sharp Healthcare. He is the Medical Director of the Scripps Whittier Institute Diabetes Program. Dr. Einhorn has held many leadership positions with the Board of the American Association of Clinical Endocrinologists, the American Medical Association's Diabetes Advisory Council and The Endocrine Society. He Chaired the American College of Endocrinology Task Force on the Insulin Resistance Syndrome and the Conference on the Insulin Resistance Syndrome. He has served on the American Diabetes Association (ADA) Managed Care Initiative and on the regional ADA and Juvenile Diabetes Foundation, and as Chair of the Diabetes and Pregnancy Program of San Diego and Imperial Counties. He is a fellow of the American College of Physicians and the American College of Endocrinology. His research and publications cover diabetes prevention and reversal, recognition and treatment of diabetic complications, new technologies, new pharmaceuticals, combination therapies, and clinical decision-making.
View Dr. Einhorn's Videos:
Visit Dr. Einhorn at the Whittier Institute for Diabetes: